Epigenetic regulation of cardiovascular differentiation

Cardiovascular Research

Volumn 90, Issue 3, 2011, Pages 404-412

  Ohtani, Kisho ^a   Dimmeler, Stefanie ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Epigenetics; Histone; Stem cells

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 7; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; PROTEIN P300; RESVERATROL; TRICHOSTATIN A;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENETIC REGULATION; HEART DEVELOPMENT; HEART MUSCLE CELL; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; HISTONES; HUMANS; METHYLATION; MODELS, CARDIOVASCULAR; MODELS, GENETIC;

EID: 79957490739     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr019     Document Type: Article

References (122)

1. Assmus B, Rolf A, Erbs S, Elsasser A, Haberbosch W, Hambrecht R et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2009;3:89-96.
2. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med 2007;167:989-997. (Pubitemid 46835786)
3. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008;28:208-216. (Pubitemid 351161191)
4. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128:707-719. (Pubitemid 46273570)
5. Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007;8:307-318. (Pubitemid 46474659)
6. Kouzarides T. Chromatin modifications and their function. Cell 2007;128:693-705. (Pubitemid 46273577)
7. Cedar H, Bergman Y. Linking DNA methylation and histone modification: Patterns and paradigms. Nat Rev Genet 2009;10:295-304.
8. Rando OJ, Chang HY. Genome-wide views of chromatin structure. Annu Rev Biochem 2009;78:245-271.
9. McKinsey TA, Zhang CL, Olson EN. Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev 2001;11:497-504. (Pubitemid 32800722)
10. Gray SG, Ekstrom TJ. The human histone deacetylase family. Exp Cell Res 2001;262: 75-83. (Pubitemid 32980246)
11. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-837. (Pubitemid 46802390)
12. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006;125:315-326.
13. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125:301-313. (Pubitemid 44313811)
14. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006;441:349-353. (Pubitemid 44050199)
15. Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007;25:1-14. (Pubitemid 46049067)
16. Rossig L, Urbich C, Bruhl T, Dernbach E, Heeschen C, Chavakis E et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005;201:1825-1835. (Pubitemid 41002901)
17. Rossig L, Li H, Fisslthaler B, Urbich C, Fleming I, Forstermann U et al. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res 2002;91:837-844. (Pubitemid 35285082)
18. Michaelis M, Michaelis UR, Fleming I, Suhan T, Cinatl J, Blaheta RA et al. Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 2004;65:520-527. (Pubitemid 38264019)
19. Gan Y, Shen YH, Utama B, Wang J, Coselli J, Wang XL. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. Biochem Biophys Res Commun 2006;340:29-34. (Pubitemid 41827643)
20. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 2005;280:24824-24838. (Pubitemid 40934573)
21. Mahpatra S, Firpo MT, Bacanamwo M. Inhibition of DNA methyltransferases and histone deacetylases induces bone marrow-derived multipotent adult progenitor cells to differentiate into endothelial cells. Ethn Dis 2010;20:S1-60-S1-64.
22. Banerjee S, Bacanamwo M. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Exp Cell Res 2010;316: 172-180.
23. Spallotta F, Rosati J, Straino S, Nanni S, Grasselli A, Ambrosino V et al. Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: Potential therapeutic implications in a mouse model of hindlimb ischemia. Stem Cells 2010;28:431-442.
24. Urbich C, Rossig L, Kaluza D, Potente M, Boeckel JN, Knau A et al. HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. Blood 2009;113:5669-5679.
25. Zeng L, Xiao Q, Margariti A, Zhang Z, Zampetaki A, Patel S et al. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol 2006;174:1059-1069. (Pubitemid 44455193)
26. Jung SB, Kim CS, Naqvi A, Yamamori T, Mattagajasingh I, Hoffman TA et al. Histone Deacetylase-3 Antagonizes Aspirin-Stimulated Endothelial Nitric Oxide Production by Reversing Aspirin-Induced Lysine Acetylation of Endothelial Nitric Oxide Synthase. Circ Res 2010;107:877-887.
27. Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A et al. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol 2003;95:2081-2088. (Pubitemid 37310394)
28. Illi B, Scopece A, Nanni S, Farsetti A, Morgante L, Biglioli P et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res 2005;96:501-508. (Pubitemid 40463458)
29. Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 2010;110: 1306-1313.
30. Chen W, Bacanamwo M, Harrison DG. Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription. J Biol Chem 2008;283:16293-16298.
31. Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 2006; 126:321-334. (Pubitemid 44092958)
32. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 2007; 21:2644-2658. (Pubitemid 47607673)
33. Potente M, Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 2008;7:2117-2122. (Pubitemid 352036236)
34. J G, CqW, Hh F, Hy D, Xl X, Ym X et al. Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. J Cardiovasc Pharmacol 2006;47:711-721.
35. Wang XB, Huang J, Zou JG, Su EB, Shan QJ, Yang ZJ et al. Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood. Clin Exp Pharmacol Physiol 2007;34:1109-1115. (Pubitemid 47416343)
36. Richter GH, Plehm S, Fasan A, Rossler S, Unland R, Bennani-Baiti IM et al. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc Natl Acad Sci USA 2009;106:5324-5329.
37. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell 2010;18:185-197.
38. Diehl F, Rossig L, Zeiher AM, Dimmeler S, Urbich C. The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation. Blood 2007;109: 1472-1478. (Pubitemid 46239578)
39. Hu M, Sun XJ, Zhang YL, Kuang Y, Hu CQ, Wu WL et al. Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling. Proc Natl Acad Sci USA 2010;107:2956-2961.
40. Olson EN. A decade of discoveries in cardiac biology. Nat Med 2004;10:467-474. (Pubitemid 38667903)
41. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 1995;9:1654-1666.
42. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998;281:108-111. (Pubitemid 28354055)
43. Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997;276:1404-1407. (Pubitemid 27235406)
44. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 1997;11:1048-1060. (Pubitemid 27199883)
45. Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 1997;11: 1061-1072. (Pubitemid 27199884)
46. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001;106:709-721. (Pubitemid 32900662)
47. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-508.
48. Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res 2006;98:1002-1013.
49. Kawamura T, Ono K, Morimoto T, Wada H, Hirai M, Hidaka K et al. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem 2005;280:19682-19688. (Pubitemid 41379492)
50. Karamboulas C, Swedani A, Ward C, Al-Madhoun AS, Wilton S, Boisvenue S et al. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J Cell Sci 2006;119:4305-4314. (Pubitemid 44774037)
51. Lee JH, Hart SR, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004;38:32-38. (Pubitemid 38197607)
52. Iezzi S, Cossu G, Nervi C, Sartorelli V, Puri PL. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc Natl Acad Sci USA 2002;99: 7757-7762. (Pubitemid 34568764)
53. Lagace DC, Nachtigal MW. Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. J Biol Chem 2004;279:18851-18860. (Pubitemid 38623312)
54. Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 2003;278:28930-28937. (Pubitemid 36935803)
55. Kook H, Lepore JJ, Gitler AD, Lu MM, Wing-Man Yung W, Mackay J et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 2003;112:863-871. (Pubitemid 38063744)
56. Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, Muscat GE. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem 2001;276: 17007-17013.
57. Lu J, McKinsey TA, Nicol RL, Olson EN. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 2000;97:4070-4075. (Pubitemid 30226088)
58. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003;100:10794-10799. (Pubitemid 37140107)
59. McBurney MW, Yang X, Jardine K, Hixon M, Boekelheide K, Webb JR et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 2003;23:38-54. (Pubitemid 36008499)
60. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009;119:2758-2771.
61. Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 2008;102:703-710. (Pubitemid 351457857)
62. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001;70: 81-120. (Pubitemid 32662206)
63. Vo N, Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 2001;276:13505-13508.
64. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996;87:953-959. (Pubitemid 26404293)
65. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D et al. Gene dosagedependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998;93:361-372. (Pubitemid 28232081)
66. Partanen A, Motoyama J, Hui CC. Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int J Dev Biol 1999;43:487-494.
67. Shikama N, Lutz W, Kretzschmar R, Sauter N, Roth JF, Marino S et al. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J 2003;22:5175-5185. (Pubitemid 37222037)
68. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003;23:3593-3606. (Pubitemid 36539192)
69. Miyamoto S, Kawamura T, Morimoto T, Ono K, Wada H, Kawase Y et al. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 2006;113: 679-690.
70. Wei JQ, Shehadeh LA, Mitrani JM, Pessanha M, Slepak TI, Webster KA et al. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 2008;118:934-946.
71. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of nonhistone proteins. Gene 2005;363:15-23.
72. Dai YS, Markham BE. p300 Functions as a coactivator of transcription factor GATA-4. J Biol Chem 2001;276:37178-37185.
73. Ma K, Chan JK, Zhu G, Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol 2005;25:3575-3582. (Pubitemid 40559564)
74. Sartorelli V, Huang J, Hamamori Y, Kedes L. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 1997;17:1010-1026. (Pubitemid 27044399)
75. Slepak TI, Webster KA, Zang J, Prentice H, O'Dowd A, Hicks MN et al. Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D. J Biol Chem 2001;276:7575-7585.
76. Kakita T, Hasegawa K, Morimoto T, Kaburagi S, Wada H, Sasayama S. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. J Biol Chem 1999;274:34096-34102. (Pubitemid 129511744)
77. Faust C, Schumacher A, Holdener B, Magnuson T. The eed mutation disrupts anterior mesoderm production in mice. Development 1995;121:273-285.
78. O'Carroll D, Erhardt S, Pagani M, Barton SC, Surani MA, Jenuwein T. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 2001;21:4330-4336. (Pubitemid 32565314)
79. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004; 23:4061-4071. (Pubitemid 39472427)
80. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001;107:323-337. (Pubitemid 33049976)
81. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 2002;16:1779-1791. (Pubitemid 34803894)
82. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ et al. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009;460:287-291.
83. Bergemann AD, Cole F, Hirschhorn K. The etiology of Wolf-Hirschhorn syndrome. Trends Genet 2005;21:188-195. (Pubitemid 40269858)
84. Li Y, Trojer P, Xu CF, Cheung P, Kuo A, Drury WJ 3rd et al. The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. J Biol Chem 2009;284:34283-34295.
85. Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K et al. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 2002;12:1052-1058. (Pubitemid 34703339)
86. Jones B, Su H, Bhat A, Lei H, Bajko J, Hevi S et al. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 2008;4:e1000190.
87. Shirai M, Osugi T, Koga H, Kaji Y, Takimoto E, Komuro I et al. The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis. J Clin Invest 2002;110:177-184. (Pubitemid 34787354)
88. Gottlieb PD, Pierce SA, Sims RJ, Yamagishi H, Weihe EK, Harriss JV et al. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 2002;31:25-32.
89. Phan D, Rasmussen TL, Nakagawa O, McAnally J, Gottlieb PD, Tucker PW et al. BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart. Development 2005;132: 2669-2678. (Pubitemid 40883264)
90. Tan X, Rotllant J, Li H, De Deyne P, Du SJ. SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos. Proc Natl Acad Sci USA 2006;103:2713-2718.
91. Sims RJ 3rd, Weihe EK, Zhu L, O'Malley S, Harriss JV, Gottlieb PD. m-Bop, a repressor protein essential for cardiogenesis, interacts with skNAC, a heart- and musclespecific transcription factor. J Biol Chem 2002;277:26524-26529. (Pubitemid 34967149)
92. Lachner M, Jenuwein T. The many faces of histone lysine methylation. Curr Opin Cell Biol 2002;14:286-298. (Pubitemid 34626966)
93. Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007;445: 214-218. (Pubitemid 46095726)
94. Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J et al. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 1995;9:1211-1222.
95. Takeuchi T. A gene trap approach to identify genes that control development. Dev Growth Differ 1997;39:127-134. (Pubitemid 27164319)
96. Lee Y, Song AJ, Baker R, Micales B, Conway SJ, Lyons GE. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res 2000;86: 932-938. (Pubitemid 30324304)
97. Takeuchi T, Kojima M, Nakajima K, Kondo S. jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He background. Mech Dev 1999;86:29-38. (Pubitemid 29371741)
98. Toyoda M, Shirato H, Nakajima K, Kojima M, Takahashi M, Kubota M et al. jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 2003;5:85-97. (Pubitemid 36827344)
99. Takeuchi T, Watanabe Y, Takano-Shimizu T, Kondo S. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev Dyn 2006;235: 2449-2459. (Pubitemid 44325259)
100. Kim TG, Chen J, Sadoshima J, Lee Y. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol Cell Biol 2004;24:10151-10160. (Pubitemid 39507855)
101. Kim TG, Jung J, Mysliwiec MR, Kang S, Lee Y. Jumonji represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2 activity. Biochem Biophys Res Commun 2005;329:544-553. (Pubitemid 40311779)
102. Jung J, Kim TG, Lyons GE, Kim HR, Lee Y. Jumonji regulates cardiomyocyte proliferation via interaction with retinoblastoma protein. J Biol Chem 2005;280: 30916-30923. (Pubitemid 41291823)
103. Mysliwiec MR, Kim TG, Lee Y. Characterization of zinc finger protein 496 that interacts with Jumonji/Jarid2. FEBS Lett 2007;581:2633-2640. (Pubitemid 46829104)
104. Shirato H, Ogawa S, Nakajima K, Inagawa M, Kojima M, Tachibana M et al. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9. J Biol Chem 2009;284:733-739.
105. Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009;139:1290-1302.
106. Shen X, KimW, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009;139: 1303-1314.
107. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev 2010;24:368-380.
108. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010;464:306-310.
109. Bose J, Gruber AD, Helming L, Schiebe S, Wegener I, Hafner M et al. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J Biol 2004;3:15.
110. Schneider JE, Bose J, Bamforth SD, Gruber AD, Broadbent C, Clarke K et al. Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique. BMC Dev Biol 2004;4:16.
111. Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science 2007;318:444-447. (Pubitemid 47614528)
112. Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 2009; 325:90-93.
113. Olave IA, Reck-Peterson SL, Crabtree GR. Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem 2002;71:755-781. (Pubitemid 34800234)
114. Ho L, Crabtree GR. Chromatin remodelling during development. Nature 2010;463: 474-484.
115. Yan Z, Wang Z, Sharova L, Sharov AA, Ling C, Piao Y et al. BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells. Stem Cells 2008;26:1155-1165.
116. Kidder BL, Palmer S, Knott JG. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 2009;27: 317-328.
117. Lickert H, Takeuchi JK, Von Both I,Walls JR, McAuliffe F, Adamson SL et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004;432:107-112. (Pubitemid 39490836)
118. Takeuchi JK, Lickert H, Bisgrove BW, Sun X, Yamamoto M, Chawengsaksophak K et al. Baf60c is a nuclear Notch signaling component required for the establishment of left-right asymmetry. Proc Natl Acad Sci USA 2007;104:846-851. (Pubitemid 46154699)
119. Takeuchi JK, Bruneau BG. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009;459:708-711.
120. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010;466:62-67.
121. Stankunas K, Hang CT, Tsun ZY, Chen H, Lee NV, Wu JI et al. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell 2008;14:298-311. (Pubitemid 351189176)
122. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-386.